bpc-157 and Esophageal-Diseases

bpc-157 has been researched along with Esophageal-Diseases* in 1 studies

Other Studies

1 other study(ies) available for bpc-157 and Esophageal-Diseases

Article	Year
Pentadecapeptide BPC 157 and the esophagocutaneous fistula healing therapy. European journal of pharmacology, 2013, Feb-15, Volume: 701, Issue:1-3 Esophagocutaneous fistulas are a failure of the NO-system, due to NO-synthase blockage by the NOS-blocker L-NAME consequently counteracted by l-arginine and gastric pentadecapeptide BPC 157 (l-arginine Topics: Animals; Arginine; Cutaneous Fistula; Drug Interactions; Esophageal Diseases; Male; NG-Nitroarginine Methyl Ester; Peptide Fragments; Proteins; Rats; Rats, Wistar; Wound Healing	2013

Article

Year

Pentadecapeptide BPC 157 and the esophagocutaneous fistula healing therapy.

European journal of pharmacology, 2013, Feb-15, Volume: 701, Issue:1-3

Esophagocutaneous fistulas are a failure of the NO-system, due to NO-synthase blockage by the NOS-blocker L-NAME consequently counteracted by l-arginine and gastric pentadecapeptide BPC 157 (l-arginine

Topics: Animals; Arginine; Cutaneous Fistula; Drug Interactions; Esophageal Diseases; Male; NG-Nitroarginine Methyl Ester; Peptide Fragments; Proteins; Rats; Rats, Wistar; Wound Healing

2013